AVO — Advanced Oncotherapy Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 0.056 | 1.01 | 3.24 | 2.32 | 4.26 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 4.28 | 1.47 | 2.22 | 0.91 | 0.225 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 12.5 | 13.7 | 22.2 | 26.3 | 30.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.18 | 4.09 | 38.5 | 38.1 | 41.1 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Total Assets | 45.4 | 59.5 | 111 | 122 | 141 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 16.7 | 8.95 | 6.48 | 19.2 | 16.1 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Liabilities | 16.7 | 25.5 | 67.9 | 78.2 | 79.9 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 28.7 | 34 | 42.9 | 44.1 | 61.4 |
Total Liabilities & Shareholders' Equity | 45.4 | 59.5 | 111 | 122 | 141 |
Total Common Shares Outstanding |